Literature DB >> 26645890

Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144.

Jun Liu1, Shuilin Xie, Yukun Wu, Meinian Xu, Chunping Ao, Wei Wang, Qinsong Zeng, Weilie Hu, Ming Li.   

Abstract

The present study aimed to determine whether actinomycin X2 (AX2) intercepted the mTOR/PTEN/PI3K/Akt signaling pathway to inhibit human prostate cancer cells (PC-3) in vitro. The effects of AX2 on mTOR, PTEN, PI3K, and Akt at the protein level and mRNA were determined by western blotting and real-time reverse transcription-PCR (RT-PCR), respectively. Concurrently, the effects of AX2 on expression levels of MiRNA144 and MiRNA126 in PC-3 were measured by real-time RT-PCR. The association of MiRNA144 with 3'-UTR of mTOR was identified using the Dual-Luciferase Reporter Gene System. The direct effect of MIRNA144 on the mTOR/PTEN/PI3K/Akt pathway was determined by real-time RT-PCR and western blotting. Apoptosis of PC-3 cells induced by AX2 was determined by MTT and flow cytometry. The results indicated that mTOR/PTEN/PI3K/Akt were decreased and PTEN was increased by AX (1, 10 µmol/l) at protein and mRNA levels in a dose-dependent manner. MiRNA144 was decreased, whereas MiRNA126 was increased by AX2. MiRNA144 associated with 3'-UTR of mTOR was corroborated. Overexpression of MiRNA144 decreased mTOR, but did not affect PTEN, PI3K, or Akt. The proliferation rates of AX2 on PC-3 cells were decreased. It suggests that AX2 induces apoptosis of PC-3 cells via meddling in the mTOR/PTEN/PI3K/Akt signaling pathway, but those effects are compounded by MiRNA144. Both AX2 and MiRNA144 intercept the signaling in different ways but cross on mTOR.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26645890     DOI: 10.1097/CAD.0000000000000309

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response.

Authors:  Andrej Herbrík; Erika Corretto; Alica Chroňáková; Helena Langhansová; Petra Petrásková; Jiří Hrdý; Matouš Čihák; Václav Krištůfek; Jan Bobek; Miroslav Petříček; Kateřina Petříčková
Journal:  Front Microbiol       Date:  2020-01-17       Impact factor: 5.640

2.  Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs.

Authors:  Ewelina Węglarz-Tomczak; Michał Talma; Mirosław Giurg; Hans V Westerhoff; Robert Janowski; Artur Mucha
Journal:  Oncotarget       Date:  2018-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.